IE
INBX icon

Israel Englander’s Inhibrx INBX Stock Holding History

Israel Englander’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.9M Sell
147,200
-180,660
-55% -$18.1M 0.01% 1962
2026
Q1 		$22M Buy
327,860
+51,943
+19% +$3.85M 0.01% 1467
2025
Q4 		$21.8M Sell
275,917
-21,903
-7% -$1.49M 0.01% 1504
2025
Q3 		$10M Buy
297,820
+22,042
+8% +$543K ﹤0.01% 2380
2025
Q2 		$3.94M Buy
275,778
+20,442
+8% +$264K ﹤0.01% 3236
2025
Q1 		$3.57M Sell
255,336
-3,052
-1% -$41.4K ﹤0.01% 3197
2024
Q4 		$3.98M Sell
258,388
-30,973
-11% -$472K ﹤0.01% 3026
2024
Q3 		$4.53M Sell
289,361
-13,835
-5% -$194K ﹤0.01% 2928
2024
Q2 		$4.3M Buy
+303,196
New +$4.74M ﹤0.01% 2862

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Israel Englander's INBX Position: Q2 2026 in Review

Israel Englander reduced its Inhibrx (INBX) stake by 55% in Q2 2026, selling an estimated $18.1M and leaving 147,200 shares worth $13.9M. The position accounts for 0.01% of the portfolio, ranked #1962.

Israel Englander first reported a position in INBX in Q2 2024 and has held it in 9 quarters since. The position peaked at $22M in Q1 2026. 163 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Israel Englander held 147,200 shares of Inhibrx worth $13.9M as of Q2 2026.
  • Israel Englander sold 180,660 Inhibrx shares in Q2 2026, an estimated $18.1M.
  • Inhibrx made up 0.01% of Israel Englander's portfolio in Q2 2026, its #1962 holding.
  • Israel Englander first reported a position in Inhibrx in Q2 2024 and has held it in 9 quarters since.
  • Israel Englander's Inhibrx position peaked at $22M in Q1 2026.
  • 163 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.